Avadel Pharmaceuticals (AVDL) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.08
-0.02
0.04
0.1

Details

Expected EPS
0.031318
Actual EPS
0.1
Surprise EPS
0.07
Surprise Percent
+219.31%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of 0.1 per share for Q3 2025.

0 Comments

Share your thoughts